Physician

Brian Roger Haney, DO

According to 2025 Medicare claims, Brian Haney, DO (NPI: 1285830554) practices hematology/oncology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from Sagadahoc, ME. This provider's primary affiliated billing organization is MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (NPI: 1205896107; TIN: 010357684) and primary practice location at 04086-1773. Haney is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Community Care Partnership of Maine, LLC (ACO ID: A2831), and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Haney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 332 traditional Medicare patients, billed 122,816 HCPCS/CPT codes, and received $2,337,741 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,371 prescription claims across 189 beneficiaries totaling $5,757,698 in drug costs, led by Revlimid (Lenalidomide). DME data shows 36 claims. Open Payments data shows 12 records totaling $9,082. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $615,972 to $2,337,741. Similarly, Part D prescription costs have moved sharply higher in recent years, from $193,547 to $5,757,698. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	185	29,543	$615,972
2018	307	88,981	$1,793,620
2019	328	139,021	$2,028,347
2020	273	126,036	$2,502,993
2021	335	131,687	$2,653,491
2022	369	142,910	$3,667,492
2023	343	159,645	$3,429,906
2024	332	122,816	$2,337,741

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	49	232	$193,547
2018	106	639	$912,113
2019	131	853	$1,422,493
2020	115	894	$2,955,379
2021	137	978	$3,641,170
2022	172	1,148	$3,993,641
2023	176	1,316	$4,723,165
2024	189	1,371	$5,757,698

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	36	$1,618

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	148	489	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	114	191	$58
80053	Blood test, comprehensive group of blood chemicals	199	807	$10
36415	Insertion of needle into vein for collection of blood sample	203	683	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	247	888	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	74	2,072	$1,316,569
Calquence	Acalabrutinib Maleate	52	1,560	$673,215
Erleada	Apalutamide	34	1,020	$496,230
Pomalyst	Pomalidomide	20	560	$411,053
Kisqali	Ribociclib Succinate	16	448	$268,193

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$775
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$617
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$9,082	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian Roger Haney, DO?

Tedicare shows public-source Medicare data for Brian Roger Haney, DO (NPI 1285830554), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Roger Haney, DO have ACO affiliation data?

Brian Roger Haney, DO is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Community Care Partnership of Maine, LLC (MSSP, ACO ID A2831), and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to Brian Roger Haney, DO?

Brian Roger Haney, DO is linked to MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (billing NPI 1205896107) in the available physician profile data.

Does Brian Roger Haney, DO have Open Payments data?

Brian Roger Haney, DO has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.